Cisplatin's Effects on Gene Expression in Glioma Cells
Author Information
Author(s): Carminati Patricia Oliveira, Mello Stephano Spano, Fachin Ana Lucia, Junta Cristina Moraes, Sandrin-Garcia Paula, Carlotti Carlos Gilberto, Donadi Eduardo Antonio, Passos Geraldo Aleixo Silva, Sakamoto-Hojo Elza Tiemi
Primary Institution: Universidade de São Paulo
Hypothesis
How do glioma cells respond to cisplatin treatment in terms of gene expression and cell survival?
Conclusion
Cisplatin treatment significantly alters gene expression in glioma cells, leading to reduced cell survival and increased apoptosis.
Supporting Evidence
- Cisplatin reduced U343 cell survival rates to less than 1% after 5 days.
- Apoptosis frequency reached 20.4% for 25 μM cisplatin after 72 hours.
- 67 genes were significantly modulated, with 29 down-regulated and 38 up-regulated.
Takeaway
This study shows that when glioma cells are treated with cisplatin, many genes change their activity, which helps the cells die more easily.
Methodology
Gene expression was analyzed using cDNA microarrays, and cell survival and apoptosis were measured after treating glioma cells with various concentrations of cisplatin.
Limitations
The study primarily focuses on one cell line, which may not represent all glioma types.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website